Low 22-item sinonasal outcome test scores in chronic rhinosinusitis: Why do patients seek treatment?

Joshua M Levy; Jess C Mace; Luke Rudmik; Zachary M Soler; Timothy L Smith

doi:10.1002/lary.26157

Low 22-item sinonasal outcome test scores in chronic rhinosinusitis: Why do patients seek treatment?

Laryngoscope. 2017 Jan;127(1):22-28. doi: 10.1002/lary.26157. Epub 2016 Jul 5.

Authors

Joshua M Levy¹, Jess C Mace¹, Luke Rudmik², Zachary M Soler³, Timothy L Smith¹

Affiliations

¹ Division of Rhinology and Sinus/Skull Base Surgery, Oregon Sinus Center, Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, Oregon, U.S.A.
² Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Calgary, Calgary, Alberta, Canada.
³ Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, U.S.A.

Abstract

Objectives/hypothesis: Patients with chronic rhinosinusitis (CRS) who experience minimal reductions in quality of life (QoL) may present for treatment despite QoL scores comparable to controls without CRS. This study seeks to identify cofactors influencing patients with CRS and low 22-item Sinonasal Outcome Test (SNOT-22) scores to seek care.

Study design: Prospective, multicenter, observational cohort.

Methods: Patients with CRS were enrolled between April 2011 and September 2015. Patients with sinonasal mucocele or unilateral sinus opacification were excluded. Control subjects without CRS were enrolled for comparison. Low-SNOT CRS was defined as a SNOT-22 score < 20.

Results: A total of 774 subjects (low-SNOT CRS, n = 38; high-SNOT CRS, SNOT-22 ≥ 20, n = 641; controls without CRS, n = 95) were enrolled. Low SNOT scores were identified in 6% of subjects with CRS. After adjustment, low-SNOT CRS and control groups without CRS reported similar baseline average SNOT-22 total scores (P = .879). Unexpectedly, compared to controls, low-SNOT CRS patients had significantly better average psychological (2.1 ± 2.3 vs. 5.8 ± 6.0; P = .030) and sleep dysfunction (2.7 ± 3.4 vs. 6.0 ± 5.2; P = .016) scores. Fourteen of 38 (37%) low-SNOT patients elected to undergo endoscopic sinus surgery (ESS), with a significantly lower likelihood of reporting a minimal clinically important difference (MCID) when compared to high-SNOT patients (43% vs. 82%; P < .001) after a mean follow-up of ∼15 months.

Conclusions: Low-SNOT CRS patients represent an outlier population for which measures of QoL fail to identify factors influencing the decision to seek treatment. Low-SNOT CRS patients electing ESS have a decreased likelihood of reporting MCIDs following ESS. Further study is required to identify novel factors associated with treatment-seeking behavior in this population.

Level of evidence: 3B Laryngoscope, 127:22-28, 2017.

Trial registration: ClinicalTrials.gov NCT01332136.

Keywords: Outcome assessment (health care); healthy volunteers; patient outcome assessment; quality of life; therapeutics.

Publication types

Multicenter Study
Observational Study
Research Support, N.I.H., Extramural

MeSH terms

Chronic Disease
Female
Humans
Male
Middle Aged
Patient Acceptance of Health Care*
Patient Reported Outcome Measures
Prospective Studies
Quality of Life*
Rhinitis / therapy*
Severity of Illness Index*
Sinusitis / therapy*

Associated data

ClinicalTrials.gov/NCT01332136

Abstract

Publication types

MeSH terms

Associated data

Grants and funding